Free-breathing multi-parametric SASHA (mSASHA) mapping provides reliable non-contrast myocardial characterization in a pediatric and adult congenital population
- PMID: 39875701
- DOI: 10.1007/s10554-025-03341-w
Free-breathing multi-parametric SASHA (mSASHA) mapping provides reliable non-contrast myocardial characterization in a pediatric and adult congenital population
Abstract
Parametric mapping has become a standard of care technique for the non-invasive assessment of myocardial edema and fibrosis. Conventional MOLLI-based T1 mapping is susceptible to many confounding effects particularly in the pediatric population. The requirement for compliant breath holds is a major limitation for younger or more ill patients. The advent of free-breathing SASHA-based multi-parametric mapping with motion correction therefore offers a significant advantage in pediatric cohorts. With IRB approval and consent/assent, children and adults with congenital heart disease underwent both conventional breath-held MOLLI-based T1 and T2 TrueFISP mapping as well as free-breathing multi-parametric SASHA assessment in the context of a clinically indicated study on a 1.5T magnet. A total of 71 subjects with mean age of 19.3 ± 8.6 years were scanned. Free-breathing multiparametric SASHA T1 and T2 values were moderately correlated with breath-held MOLLI/T2p-bSSFP (r = 0.52). Importantly free-breathing SASHA-based T1 maps were able to discriminate between patients with late gadolinium enhancement with a statistically significant difference in mean T1 values (p = 0.03). Free-breathing multiparametric SASHA allows for reliable myocardial characterization with moderate correlation to conventional breath-held T1 and T2 mapping techniques in a small and heterogenous sample of pediatric and congenital cardiac subjects.
Keywords: Free-breathing; Parametric mapping; Pediatric cardiology; SASHA.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Ethical approval: The study was approved by the Children’s National Medical Center IRB with signed consent/assent by the study subjects. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
References
-
- Messroghli DR, Walters K, Plein S et al (2007) Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med 58(1):34–40. https://doi.org/10.1002/mrm.21272 - DOI - PubMed
-
- Schelbert EB, Messroghli DR (2016) State of the art: clinical applications of cardiac T1 mapping. Radiology 278(3):658–676. https://doi.org/10.1148/radiol.2016141802 - DOI - PubMed
-
- aus dem Siepen F, Buss SJ, Messroghli D et al (2015) T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 16(2):210–216. https://doi.org/10.1093/ehjci/jeu183 - DOI - PubMed
-
- Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagi. J Cardiovasc Magn Reson 19:1–24. https://doi.org/10.1186/s12968-017-0389-8 - DOI
-
- Olivieri LJ, Kellman P, McCarter RJ, Cross RR, Hansen MS, Spurney CF (2016) Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy. J Cardiovasc Magn Reson 18(1). https://doi.org/10.1186/s12968-016-0292-8
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
